Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.

By Samantha E Hansford, P. Kaurah, H. Li-Chang, M. Woo, J. Senz, H. Pinheiro, K. Schrader, D. Schaeffer, K. Shumansky, G. Zogopoulos and 25 more. JAMA Oncology, 2015

666 citations recorded by the source corpus.

Subfields: Molecular Biology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/103590e50d7b1b00d39cccc134521101d91d2bad

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Machlowska
2. J. Baj
3. M. Sitarz
4. R. Maciejewski
5. T. He
6. Bo Huang
7. Yan Lei
8. Bo Liu

Citations in the corpus

• Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis (2018, background): “While the affected individuals develop a rare type of stomach cancer, invasive lobular breast cancer is the second most frequent type of neoplasia.(258,259) Epigenetics and non-coding RNAS in breast cancer”
• Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies (2020, background): “Among CDH1 mutation-negative patients within HDGC families, there were displayed candidate mutations within genes of high and moderate penetrance, like: BRCA2, STK11, ATM, SDHB, PRSS1, MSR1, CTNNA1 and PALB2 [62].”